Analysis of Recurrent Stroke Volume between VKA (Vitamin K Antagonist) and Three NOACs (Non-Vitamin K Antagonist Oral Anticoagulants) under Oral Anticoagulant Therapy : Figure 1

Figure 1: Two arms of NOACs administration.
NVAF: Nonvalvular Atrial Fibrillation, NOACs: Non-vitamin K Antagonist Oral Anticoagulants.